Are you one of the estimated 1.5 million Australians who suffer with a sleep disorder?*
* Deloitte Access Economics. Reawakening Australia: the economic cost of sleep disorders in Australia, 2010. Canberra, Australia.
** Hart C, Lavery D, Czyniewski S, Beer F. Effects of a Novel Mandibular Advancement Device on AHI and Snoring in Patients with Obstructive Sleep Apnea: A Pilot Study. The study has been accepted for publication in the Journal of Dental Sleep Medicine, and it is available at http://www.jdsm.org/AcceptedPapers.aspx.
Welcome to the unique alternative for snorers and sufferers of mild-to-moderate obstructive sleep apnoea (OSA). The Oventus Treatment Platform may also offer a suitable alternative to those who cannot tolerate Continuous Positive Airway Pressure (CPAP). OSA is a serious condition, so speak to your healthcare professional for a diagnosis and to discuss if an oral device could help you.
An Oventus clinical trial showed that 100% of patients experienced a significant reduction in snoring with 82% eliminating snoring completely and 76% reducing their Apnoea Hypopnea Index (AHI) by more than half.**
Now is the time to explore the possibility that this treatment could really work for you.